BIOMAT Database Logo BIOMAT Database Logo

Synthesis and Anticancer Properties of Novel Truncated Carbocyclic Nucleoside Analogues. 2018

Balija Sivakrishna, and Sehbanul Islam, and Amarendra Panda, and Maddi Saranya, and Manas K Santra, and Shantanu Pal
Organic Chemistry Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar, Orissa 751007, India.

Modified nucleosides established a prime role as therapeutic drugs. Design and synthesis of novel truncated carbocyclic nucleoside with modified nucleobases and evaluation of their anticancer properties. Novel truncated carbocyclic nucleoside analogues were synthesized from a versatile starting material D-ribose. The synthetic route includes stereoselective Grignard reaction, Wittig olefination, ring closing metathesis, double bond hydrogenation and Mitsunobu nucleobase condensation as the key steps. Cytotoxicity was measured using MTT assay in breast cancer cell lines (MCF7 and MDA-MB-231), ovarian cancer cell lines (IGROV1 and OVCAR8). The synthesized compounds were characterized using spectroscopy techniques. The synthesized compounds induced cytotoxicity in breast cancer cell lines (MCF7 and MDA-MB-231), ovarian cancer cell lines (IGROV1 and OVCAR8) while minimal effect on primary cell line. Among the eight analogues, 1b and 1d showed the highest cytotoxicity effect and induced autophagy mode of cell death. These compounds induced autophagy by inactivating AKT and mTOR pathway. In addition, PARP1 was found to be stabilized upon treatment with compound 1b and 1d and is one of the known markers associated with induction of autophagy through the AMPK/mTOR pathway after DNA damage. Taken together, these results suggest that compounds 1b and 1d inhibit cancer cell proliferation through mTOR inactivation-mediated induction of autophagy.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D061986 MCF-7 Cells An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.) MCF7 Cells,Michigan Cancer Foundation 7 Cells,Cell, MCF-7,Cell, MCF7,Cells, MCF-7,Cells, MCF7,MCF 7 Cells,MCF-7 Cell,MCF7 Cell

Related Publications

Balija Sivakrishna, and Sehbanul Islam, and Amarendra Panda, and Maddi Saranya, and Manas K Santra, and Shantanu Pal
[Synthesis of analogues of carbocyclic nucleoside].
January 1991, Yao xue xue bao = Acta pharmaceutica Sinica,
Balija Sivakrishna, and Sehbanul Islam, and Amarendra Panda, and Maddi Saranya, and Manas K Santra, and Shantanu Pal
Synthesis and anticancer activities of novel 8-azapurine carbocyclic nucleoside hydrazones.
October 2015, Bioorganic & medicinal chemistry letters,
Balija Sivakrishna, and Sehbanul Islam, and Amarendra Panda, and Maddi Saranya, and Manas K Santra, and Shantanu Pal
Synthesis of fluorinated carbocyclic pyrimidine nucleoside analogues.
December 2022, Organic & biomolecular chemistry,
Balija Sivakrishna, and Sehbanul Islam, and Amarendra Panda, and Maddi Saranya, and Manas K Santra, and Shantanu Pal
Transition-metal-mediated synthesis of novel carbocyclic nucleoside analogues with antitumoral activity.
October 2004, Chemistry (Weinheim an der Bergstrasse, Germany),
Balija Sivakrishna, and Sehbanul Islam, and Amarendra Panda, and Maddi Saranya, and Manas K Santra, and Shantanu Pal
Asymmetric synthesis of novel apio carbocyclic nucleoside analogues as potential antiviral and antitumor agent.
January 2007, Nucleosides, nucleotides & nucleic acids,
Balija Sivakrishna, and Sehbanul Islam, and Amarendra Panda, and Maddi Saranya, and Manas K Santra, and Shantanu Pal
Unsaturated and carbocyclic nucleoside analogues: synthesis, antitumor, and antiviral activity.
January 1991, Journal of medicinal chemistry,
Balija Sivakrishna, and Sehbanul Islam, and Amarendra Panda, and Maddi Saranya, and Manas K Santra, and Shantanu Pal
Stereoselective synthesis of a novel carbocyclic nucleoside.
November 2001, The Journal of organic chemistry,
Balija Sivakrishna, and Sehbanul Islam, and Amarendra Panda, and Maddi Saranya, and Manas K Santra, and Shantanu Pal
Synthesis and properties of oligonucleotides containing carbocyclic L-nucleoside analogues with a restricted glycosyl conformation.
January 1999, Nucleic acids symposium series,
Balija Sivakrishna, and Sehbanul Islam, and Amarendra Panda, and Maddi Saranya, and Manas K Santra, and Shantanu Pal
Synthesis of novel apio carbocyclic nucleoside analogues as selective a(3) adenosine receptor agonists.
June 2005, The Journal of organic chemistry,
Balija Sivakrishna, and Sehbanul Islam, and Amarendra Panda, and Maddi Saranya, and Manas K Santra, and Shantanu Pal
Stereoselective synthesis of carbocyclic analogues of the nucleoside Q precursor (PreQ0).
January 2014, Beilstein journal of organic chemistry,
Copied contents to your clipboard!